Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06286657
Status:
RECRUITING
Last Update Posted:
2024-02-29
First Post:
2024-01-17
Brief Title:
Xanthohumol and Viral Infections XL
Sponsor:
University of Vienna
Organization:
University of Vienna
Study Overview
Official Title:
Xanthohumol in the Prevention of Virus-mediated Upper Respiratory Tract Infections in Humans
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration ofviral infections
Detailed Description:
In this placebo-controlled study blood is taken on the first day of the study followed by a 90-day intervention with xanthohumol or a placebo which is taken twice daily Blood samples will be taken on day 0 day 45 and day 90 Should the study participants develop a respiratory infection during the study they will be asked to perform a self-test
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None